Condition No.
|
Document Title
|
3.4 |
Monthly EM&A Report (Sep 2019)(HY/2018/02)
|
3.3 |
Baseline Monitoring Report (HY/2018/02)
|
3.4 |
Monthly EM&A Report (Oct 2019)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Nov 2019)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Dec 2019)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Jan 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Feb 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Mar 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Apr 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (May 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Jun 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Jul 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Aug 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Sep 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Oct 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Nov 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Dec 2020)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Jan 2021)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Feb 2021)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Mar 2021)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (Apr 2021)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (May 2021)(HY/2018/02)
|
3.4 |
Monthly EM&A Report (June 2021)(HY/2018/02)
|